Ultragenyx Pharmaceutical reported $-132544000 in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -112.5M 68.38M
Agios Pharmaceuticals AGIO:US $ -98.67M 3.96M
Alnylam Pharmaceuticals ALNY:US $ -137.27M 45.91M
Aptinyx Inc APTX:US $ -19279000 207K
Biocryst Pharmaceuticals BCRX:US $ -49.64M 2.37M
Biomarin Pharmaceutical BMRN:US $ 56.67M 96.56M
Epizyme EPZM:US $ -49.63M 0.33M
Esperion Therapeutics ESPR:US $ -42836000 611K
Insmed INSM:US $ -98173000 1.78M
IONIS PHARMACEUT IONS:US $ -53.21M 278.25M
Karyopharm Therapeutics KPTI:US $ -34409000 81.51M
Kyowa Hakko Kirin 4151:JP Y 20678M 120M
Mirati Therapeutics MRTX:US $ -183.59M 12.92M
Moderna Inc MRNA:US 4.31B 1.18B
Ptc Therapeutics PTCT:US $ -60.21M 5.71M
Puma Biotechnology PBYI:US $ 1.52M 7.59M
Regeneron Pharmaceuticals REGN:US $ 1360.9M 1353.3M
Sarepta Therapeutics SRPT:US $ -76.16M 19.51M
Ultragenyx Pharmaceutical RARE:US $ -132.54M 33.51M
Vertex Pharmaceuticals VRTX:US $ 1069.3M 159.74M
Vital Therapies VTL:US $ -21.41M 0.26M
Xoma XOMA:US $ -2063000 32.43M